Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Chimerix Inc (CMRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 179,266
  • Shares Outstanding, K 51,073
  • Annual Sales, $ 7,220 K
  • Annual Income, $ -69,470 K
  • 60-Month Beta 1.47
  • Price/Sales 24.70
  • Price/Cash Flow N/A
  • Price/Book 1.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.37
  • Number of Estimates 2
  • High Estimate -0.24
  • Low Estimate -0.49
  • Prior Year -0.39
  • Growth Rate Est. (year over year) +5.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.50 +40.40%
on 04/25/19
3.78 -7.14%
on 05/15/19
+0.79 (+29.04%)
since 04/23/19
3-Month
1.74 +101.72%
on 03/08/19
3.78 -7.14%
on 05/15/19
+1.59 (+82.81%)
since 02/22/19
52-Week
1.74 +101.72%
on 03/08/19
5.04 -30.36%
on 07/06/18
-1.14 (-24.52%)
since 05/23/18

Most Recent Stories

More News
Will Chimerix to Surge Higher?

As of late, it has definitely been a great time to be an investor Chimerix.

CMRX : 3.51 (+0.57%)
Look for Shares of Chimerix Inc to Potentially Pullback after Yesterday's 9.42% Rise

Chimerix Inc (NASDAQ:CMRX) traded in a range yesterday that spanned from a low of $3.29 to a high of $3.65. Yesterday, the shares gained 9.4%, which took the trading range above the 3-day high of $3.30...

CMRX : 3.51 (+0.57%)
Chimerix (CMRX) Reports Q1 Loss, Tops Revenue Estimates

Chimerix (CMRX) delivered earnings and revenue surprises of 0.00% and 17.80%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

CMRX : 3.51 (+0.57%)
Chimerix: 1Q Earnings Snapshot

DURHAM, N.C. (AP) _ Chimerix Inc. (CMRX) on Thursday reported a loss of $17.7 million in its first quarter.

CMRX : 3.51 (+0.57%)
Chimerix, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 9, 2019 / Chimerix, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 9, 2019 at 8:30 AM Eastern Time.

CMRX : 3.51 (+0.57%)
Chimerix to Announce First Quarter 2019 Financial Results on May 9, 2019

Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that it will host a live conference call and audio webcast...

CMRX : 3.51 (+0.57%)
Watch for Chimerix Inc to Potentially Pullback After Gaining 7.36% Yesterday

Chimerix Inc (NASDAQ:CMRX) traded in a range yesterday that spanned from a low of $2.73 to a high of $2.77. Yesterday, the shares gained 7.4%, which took the trading range above the 3-day high of $2.72...

CMRX : 3.51 (+0.57%)
Research Report Identifies Chimerix, Evolent Health, ABIOMED, Syndax Pharmaceuticals, Independence Realty Trust, and Selecta Biosciences with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Chimerix, Inc. (NASDAQ:CMRX),...

EVH : 13.90 (-4.14%)
ABMD : 262.64 (-1.07%)
SNDX : 7.32 (unch)
IRT : 10.96 (-0.18%)
SELB : 2.24 (-8.94%)
CMRX : 3.51 (+0.57%)
Latest Biotechnology Advancements may be Key to Unlock new Autism Treatments

According to the Centers for Disease Control, autism affects an estimated 1 in 59 children in the United States today. The Autism Speaks website defines the main problem for researchers/practitioners...

QBIO : 1.6100 (-4.17%)
GERN : 1.52 (-0.65%)
INSM : 25.82 (-0.08%)
PHAS : 9.87 (-6.71%)
CMRX : 3.51 (+0.57%)
Look for Shares of Chimerix Inc to Potentially Pullback after Yesterday's 20.10% Rise

Chimerix Inc (NASDAQ:CMRX) traded in a range yesterday that spanned from a low of $2.32 to a high of $2.56. Yesterday, the shares gained 20.1%, which took the trading range above the 3-day high of $2.14...

CMRX : 3.51 (+0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade CMRX with:

Business Summary

Chimerix, Inc. engages in the discovery, development and commercialization of oral antiviral therapeutics for various medical needs. The Company is developing various product candidates for the treatment of dsDNA viruses, HIV, hepatitis C, influenza and smallpox which are under different phases of clinical...

See More

Key Turning Points

2nd Resistance Point 3.64
1st Resistance Point 3.58
Last Price 3.51
1st Support Level 3.42
2nd Support Level 3.32

See More

52-Week High 5.04
Fibonacci 61.8% 3.78
Last Price 3.51
Fibonacci 50% 3.39
Fibonacci 38.2% 3.00
52-Week Low 1.74

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar